XCOM: Enemy Within
2013 video game / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about XCOM: Enemy Within?
Summarize this article for a 10 year old
XCOM: Enemy Within is an expansion pack for the turn-based tactical video game XCOM: Enemy Unknown. The expansion pack primarily adds new gameplay elements to the base game, as well as introducing new themes of transhumanism via aggressive gene therapy.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
XCOM: Enemy Within | |
---|---|
Developer(s) | Firaxis Games |
Publisher(s) |
|
Producer(s) | Clint McCaul Garth DeAngelis |
Designer(s) | Ananda Gupta |
Programmer(s) | Justin Boswell |
Artist(s) | David Black |
Writer(s) |
|
Composer(s) | Michael McCann |
Series | XCOM |
Engine | Unreal Engine 3 |
Platform(s) | Microsoft Windows, Linux, OS X, iOS, Android, PlayStation Vita, PlayStation 3, Xbox 360 |
Release | |
Genre(s) | Turn-based tactics |
Mode(s) | Single-player, multiplayer |
XCOM: Enemy Within was released for Microsoft Windows, PlayStation 3, and Xbox 360 in November 2013 and received generally favorable reviews from critics. In June 2014, Feral released both XCOM: Enemy Within and its base game XCOM: Enemy Unknown for Linux. The game also came to the iOS App Store and Google Play Store a year after the initial release, on November 12, 2014. On March 22, 2016, the game was released on the PlayStation Store for PlayStation Vita.
The Windows, OS X and Linux editions require XCOM: Enemy Unknown to play; Enemy Within was released for Xbox 360 and PlayStation 3 as part of the Commander Edition bundle with Enemy Unknown. The iOS and Android versions were released as stand-alone apps not requiring the original mobile port of Enemy Unknown to play. The PlayStation Vita version is only available bundled with Enemy Unknown under the title, XCOM: Enemy Unknown Plus.